financetom
Business
financetom
/
Business
/
Japan's Norinchukin ekes out small profit, flags risks in private credit market
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Japan's Norinchukin ekes out small profit, flags risks in private credit market
Nov 19, 2025 1:30 AM

*

Says taking a cautious approach to new investment

*

There's concern about overheating in private credit

markets, CEO

says

*

Bank suffered huge losses last year as value of overseas

bond

holdings crashed

(Recasts and writes through)

By Anton Bridge

TOKYO, Nov 19 (Reuters) - Japan's Norinchukin Bank

, hit hard by mammoth losses last year, logged a small

profit for a second straight quarter and said that it has begun

increasing its investments in securities.

But the bank, one of the world's largest investors in

collateralised loan obligations (CLOs), also noted that markets,

particularly private credit markets, had been volatile of late

and a cautious approach to new investment was warranted.

"We are beginning to see concern that there's overheating in

credit market, particularly private credit markets," Chief

Executive Taro Kitabayashi told a press briefing.

"It's not that everyone will go under, but that as high

interest rates have persisted in the U.S., we are starting to

see winners and losers," he added.

The bank reported net profit of 26 billion yen ($167

million) for July-September, compared with a 481 billion yen

loss for the same period a year earlier.

A joint venture between Norinchukin and Mitsui & Co ( MITSF )

that had exposure to the bankrupt auto parts maker First Brands

Group revised down its net profit forecast for this financial

year by 36.4 billion yen.

This has not yet been fully fed into Norinchukin's results,

Chief Financial Officer Masaki Nagano said.

Last year, the bank posted an annual loss of $12.6 billion,

brought about by huge losses in U.S. and European sovereign

bonds that crashed in value when interest rates rose from 2022

and stayed higher for longer than it anticipated.

Norinchukin is Japan's primary financial institution for

farm, forestry and fishery cooperatives. It earns most of its

money through returns from securities investment rather than

lending.

It has boosted its investments in CLOs, which grew to 9.7

trillion yen at the end of September, up nearly 50% from 6.5

trillion yen a year prior.

Norinchukin may increase its CLO holdings in the short term,

Nagano said, adding that in the medium and long term the bank

expects CLOs as a proportion of its assets to stay broadly flat.

Norinchukin, which still had 1.14 trillion yen of unrealised

losses in its bond portfolio at end-September, maintained its

full-year profit forecast of 30 billion to 70 billion yen.

The bank has said it will use bond sale proceeds for new

investment, including in Japanese government bonds, equities,

real estate, private equity and infrastructure.

($1 = 155.3700 yen)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Data center REIT Fermi upsizes US IPO
Data center REIT Fermi upsizes US IPO
Sep 29, 2025
Sept 29 (Reuters) - Data center real estate investment trust Fermi upsized its U.S. initial public offering on Monday, aiming to sell 32.5 million shares, compared to its previous target of 25 million. (Reporting by Ateev Bhandari in Bengaluru) ...
BRIEF-Novartis Announces Commencement Of Tender Offer To Acquire Tourmaline Bio
BRIEF-Novartis Announces Commencement Of Tender Offer To Acquire Tourmaline Bio
Sep 29, 2025
Sept 29 (Reuters) - NOVARTIS AG: * NOVARTIS ANNOUNCES COMMENCEMENT OF TENDER OFFER TO ACQUIRE TOURMALINE BIO * TORINO MERGER SUB INC COMMENCED A TENDER OFFER TO ACQUIRE ALL OF OUTSTANDING SHARES OF COMMON STOCK, PAR VALUE $0.0001 PER SHARE OF TOURMALINE BIO, INC AT A PRICE OF $48 PER SHARE, IN CASH, WITHOUT INTEREST * OFFER WILL EXPIRE AT...
TotalEnergies' $950 million US solar sale is meant to calm debt concerns on Investor Day
TotalEnergies' $950 million US solar sale is meant to calm debt concerns on Investor Day
Sep 29, 2025
* Total to sell 50% of US solar portfolio for $950 million * Bought 49% of upstream US gas assets for undisclosed sum * CEO under pressure to lower 18% net debt-to-equity ratio with divestments * Company last week announced trimmed buybacks to cut spending * By America Hernandez Sept 29 (Reuters) - TotalEnergies will raise $950 million from the...
IO Biotech Advised Against Filing Biologics License Application for Cylembio; Plans to Cut 50% of Workforce
IO Biotech Advised Against Filing Biologics License Application for Cylembio; Plans to Cut 50% of Workforce
Sep 29, 2025
08:00 AM EDT, 09/29/2025 (MT Newswires) -- IO Biotech ( IOBT ) said Monday the US Food and Drug Administration recommended it not submit a Biologics License Application for Cylembio based on results from the IOB-013 clinical trial, which failed to meet statistical significance. The company said it will continue discussions with the FDA on the design of a potential...
Copyright 2023-2026 - www.financetom.com All Rights Reserved